Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1368867 | Bioorganic & Medicinal Chemistry Letters | 2014 | 7 Pages |
Abstract
MAP4K4 has been shown to regulate key cellular processes that are tied to disease pathogenesis. In an effort to generate small molecule MAP4K4 inhibitors, a fragment-based screen was carried out and a pyrrolotriazine fragment with excellent ligand efficiency was identified. Further modification of this fragment guided by X-ray crystal structures and molecular modeling led to the discovery of a series of promising compounds with good structural diversity and physicochemical properties. These compounds exhibited single digit nanomolar potency and compounds 35 and 44 achieved good in vivo exposure.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Lan Wang, Mark Stanley, Jason W. Boggs, Terry D. Crawford, Brandon J. Bravo, Anthony M. Giannetti, Seth F. Harris, Steven R. Magnuson, Jim Nonomiya, Stephen Schmidt, Ping Wu, Weilan Ye, Stephen E. Gould, Lesley J. Murray, Chudi O. Ndubaku, Huifen Chen,